Paul Hopper - Jun 1, 2021 Form 4 Insider Report for Scopus BioPharma Inc. (SCPS)

Role
Director
Signature
/s/ Paul Hopper
Stock symbol
SCPS
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
11/17/2021, 08:48 AM
Previous filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPS Common Stock Other +700K $1.4M Jun 1, 2021 By Moreglade Pty. Limited F1, F2
transaction SCPS Common Stock Other +6.33K $12.7K Jun 1, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued as partial consideration for the sale of Bioscience Oncology Pty. Ltd. to the issuer on June 10, 2020 pursuant to the Conditional Stock Purchase Agreement dated as of June 8, 2020 among the issuer, as purchaser, and Mr. Hopper and the other sellers party thereto, as sellers.
F2 Mr. Hopper is a director of Moreglade Pty. Limited and therefore is deemed to have shared voting and dispositive power over the shares of Common Stock held by this entity. Mr. Hopper disclaims beneficial ownership of the shares of Common Stock held by this entity, as he has no pecuniary interest therein.
F3 Excludes 12,666 shares owned by Mr. Hopper's spouse and an aggregate of 101,336 shares owned by Mr. Hopper's adult children, as to which shares he disclaims beneficial ownership.